Reach Us +44-1202-068036
Global Tests Evaluating the Functional Condition of Hemostasis | OMICS International
ISSN: 2161-1459
Journal of Clinical & Experimental Pharmacology

Like us on:

Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Global Tests Evaluating the Functional Condition of Hemostasis

Solovyev MA1*, Tutrin II2, Udut VV1,2, Borodulina EV1 and Turenko AV2

1Research Institute of Pharmacology and Regenerative Medicine name of E.D.Goldberg, Russia

2Tomsk State University, Russia

*Corresponding Author:
Solovyev MA
Research Institute of Pharmacology
and Regenerative Medicine name of E.D.Goldberg
15A Nikitina street, apt.8, Tomsk oblast
Tomsk, 634029, Russian Federation
Tel: +7-913-10-888-07
E-mail: [email protected]

Received Date: May 21, 2015; Accepted Date: June 22, 2015; Published Date:June 26, 2015

Citation: Solovyev MA, Tutrin II, Udut VV, Borodulina EV, Turenko AV (2015) Global Tests Evaluating the Functional Condition of Hemostasis. Clin Exp Pharmacol 5:178. doi: 10.4172/2161-1459.1000178

Copyright: © 2015 Solovyev MA et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Journal of Clinical & Experimental Pharmacology


Control of effectiveness of global tests evaluation of the functional state regulation of blood aggregation provided an opportunity to obtain timely information about the I-II and III phases of hemostasis while using native substrate - whole blood. Ex vivo, registered during hemocoagulation of changing the viscous characteristics of whole blood, allowed to formulate the concept of fibrinogenesis permanence as in vivo existing process, defining proper hemostatic potential – integrative characteristic of the entire cycle of hemocoagulation, ensuring necessary blood fluidity and restricting extravasation of its components in case of defecting its permeability or damaging its vascular wall.


Regulation system of aggregate blood condition; Hemocoagulation; Hemostatic potential; Whole blood; Global methods; Low-frequency thromboelastography


In recent years, the increase of mortality rates in the world is the result of a variety of diseases associated with thrombosis or hemorrhage. Also, new data on the role of endothelial function in ensuring system RBA has been gained as well as its impact on thromboresistance, vascular tone and permeability, adhesion of blood cells and angiogenesis. This allowed considering endothelial dysfunction (ED) as a key link in the pathogenesis of atherosclerosis, coronary heart disease, hypertension cancer, diabetes, preeclampsia and many other diseases. For the analysis of system RBA, clotting, amidolytic and immunferment methods are used [1-3]. Detailed evaluation of conducted studies reveals a number of disadvantages, such as lack of standardization, continuous sample preparation, low sensitivity, and most importantly, all the methods are made on the model of citrate plasma [4-7]. Thus, constantly developing new technologies, aiming to identify the genetic thrombophilia, markers of endothelial dysfunction, antiphospholipid antibodies and etc., cannot solve the problem of timely diagnosis and prevention of thrombosis and thrombohemorrhagic complications [7-10]. The global trend - the personification of research in the mode “point-ofcare test», using “global” test evaluation system RBA, becomes popular. The main methods of this direction are the thrombin generation test (TGT), thromboelastography (TEG), turbidimetric fibrin formation (TFF), fourier-converting mechanical spectroscopy (FCMS) and lowfrequency piezoelectric thromboelastography (LFPTEG) [8,11-14]. This article uses comparative analysis in order to to determine their effectiveness in the evaluation of system RBA.


The study was conducted on the basis of clinics of Research Institute of Pharmacology and Regenerative Medicine name of E.D. Goldberg involving 150 conditionally healthy volunteers (mean age 22 ± 6,5 years), after signing a free and informed consent.

As a model of the medium TFF, TGT was used citrate plasma, FCMS, TEG, LFPTEG the original substance - whole blood [8,9,14,15]. The standardization of sample preparation stage of LFPTEG has the following conditions:

• 1 ml of blood from the cubital vein without applying tourniquet;

• 3-component siliconized syringe, V = 2,5 ml;

• single cuvette from medical grade plastic, V = 0,45 ml;

• immediately (10-12 seconds) start of research.

We analyzed the results of “global” test evaluation system RBA such as TEG, TFF, LFPTEG and thrombin generation test (TGT). These FCMS were used as a historical control, since Russia does not have a device for carrying out this research [8]. To register the blood coagulation process using technology LFPTEG, a new technological apparatus of low-frequency piezoelectric tromboelastograph was used (hardware-software complex ARP-01M “Mednord”, Russia, registration certificate Rosreestr ?2010/09767) [6,16,17]. The analysis of coagulation graph is represented on (Figure 1).


Figure 1: A graph of changes condition of blood aggregation (LFPTEG) healthy volunteer, which is estimated along the ordinate axis the amplitude research process
(A1) in relative units (r.u.) and the abscissa axis – time or research (T1) in minutes
?0 – initial value of the amplitude at the moment of time t0, in r.u.;
t1 – period of reaction (time from the beginning of research to maximum decrease of amplitude LFPTEG – ?1, in minute;
A1 – maximum decrease in amplitude of the time «t1» (period of reaction), in r.u.;
t2 – time to achieve the amplitude ?2 LFPTEG, in minute;
A2 – increase of the amplitude LFPTEG on 100 r.u. (A2-A1), in r.u.;
t3 – blood coagulation time (point of gelling) is determined automatically when you change tg angle of the curve 50%, in minute;
A3 – amplitude at the point of gelling LFPTEG, in r.u.;
A4 – amplitude LFPTEG after 10 minutes reaching attaining point of gelling, in r.u.;
t5 – time of achievement maximum amplitude LFPTEG (A5) (time of formation a fibrin-platelet clot structure), in minute;
A6 – amplitude LFPTEG after 10 minutes reaching the maximum amplitude, in r.u.

These quantitative data were processed using the programs Microsoft Excel and SPSS 13.0. The first stage has been tested the normality of distribution of quantitative indicators using the Kolmogorov - Smirnov. Then there was a statistical description of the various groups involved in the study, using nonparametric methods. Evaluated quantitative data presented in the form of Me [LQ; UQ] (where Me - median, LQ - the bottom quartile, UQ - top quartile). To test the statistical hypotheses about the difference between the study groups used the nonparametric Mann-Whitney test (where p - the current level of significance) [18].


During the assessment of the hemostatic potential, it is necessary to include all elements of the system RBA in the study, because one cannot exclude the effect of inescapable stressor - a standardized contact activation of coagulation process (const. V seu S cuvette) that is achieved by mode «point - of - care test», or studies ex vivo. Evidences show that, in order to achieve maximum reliability of obtaining the results, all studies should be performed using whole blood. Indeed, the whole blood sample, containing aliquots of endothelial producers (some of which trigger effects in a limited time interval from 1•10-3 to 30 sec), formed elements of blood and plasma factors hemostasis, used for operative analysis, provides an opportunity of obtaining objective information about the “time slice” state of hemostatic potential (HP) and viability function of the endothelium [7,13].

Picture 2 shows a graph of blood coagulation, obtained by means of TFF, TEG, LFPTEG, TGT, FCMS. From the represented data, of the process of lateral assembly and the formation of cross-linked fibrin takes ≈ 30 ± 5 minutes and is determined by almost all methods. “Point of gelling” (blood coagulation time) is the key indicator of the process start of clot formation - transition in the coagulation of blood from a liquid (sol) into a solid (gel). This is estimated only in two ways: FCMS and LFPTEG. Fibrinolytic activity was evaluated by TEG, FCMS and LFPTEG. As for the initial phase of coagulation, its analytical estimation is possible only with the use of LFPTEG. For all other methods, the determined step is regarded as a «lag time» (TGT, TFF), reaction time (TEG), the phase of pre-emerging clot (FCMS) [2].

The graphs (Figure 2) representing the registered blood clotting process to TEG «lag time» until the lateral assembly; for FCMS «lag time» takes place until “gelation point”, and the TGT, describing the kinetics of thrombin activity, also has a «lag time» in the time interval 2-3 minutes when setting and within ≈ 30 minutes due to sample preparation (taking into account the fact that the coagulation process takes place even in the stabilized blood.


Figure 2: Graphs of blood coagulation, obtained by the methods: 1- THT; 2-TEG; 3- LFNTEG, 4- TFF, 5-FCMS.

Thus, among the “global” tests to evaluate the HP in whole blood, the closest to the observance of the fundamental requirements for the research methods of hemostasis (efficiency, availability, informativity, reliability) is LFPTEG. The results are graphically overlay registration process of whole blood clotting obtained by LFPTEG on a constructed hypothetical model of coagulation. This overlap, reflecting all the stages, was the basis for a new view on system RBA as resulting participation geographically and functionally separates its units (vascular-platelet, coagulation, anticoagulant and fibrinolytic) to ensure proper HP where, in vivo, the process fibrinogenesis in terms of activation, management and restrictions is present permanently (Figure 3).


Figure 3: Graph of low-frequency thromboelastography is approximated on a modified version blood coagulation pathway.

From positions of system analysis, the resulting functions of the system RBA in vivo is HP of whole blood, and ensuring its consistency over time is determined by nonlinear on time process fibrinogenesis with known and already axiomatic stages of initiation / amplification, propagation, lateral assembly, formation of cross-linked fibrin, until retraction and lysing of the clot. Temporary determinant nonlinearity fibrinogenesis determined enzymatic potential endothelialintravascular continuum. While not disputing the main provisions of the title role of thrombin in that process it should be understood that it is its amount (level) [14], and most likely – activity [7] that regulated by anticoagulant potential, provides protein C, and S, thrombomodulin, AT III, α2-macroglobulin, NO and prostacyclin, determines the completeness or incompleteness fibrinogenesis in terms of deterrence and limit its rate of formation of metabolic products of fibrinogen and producers of the vascular wall. Thus, in vivo, a second and even a millisecond required for thrombin generation are sufficient to initiate fibrinogenesis, but its viability is directly dependent on the intensity formation and size of thrombin pool, together with the characteristics of blood flow in different parts of vascular channel [19].


Thus, in view of the existence of a multitude of methods for studying the hemostatic system, it is necessary to distinguish between methods that evaluate the viscoelastic properties of the blood, provided the length of the control scale and timing of deformation, in contrast to other more simple techniques that give the most complete picture of the hemostatic system. Currently, there are a large number of devices that allow for LFPTEG, TEG, TGT, etc., but we must remember that it is necessary to strive for maximum production of early research results system of RBA, close to the bedside, and receive all the information about the picture forming pre-emerging bunch.


Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

  • 13th International Conference on Biosimilars and Biologics
    November 14-15, 2018 Lisbon, Portugal
  • 14th International Conference on Generic Drugs and Biosimilars
    November 15-16, 2018 Berlin, Germany

Article Usage

  • Total views: 12213
  • [From(publication date):
    July-2015 - Oct 23, 2018]
  • Breakdown by view type
  • HTML page views : 8396
  • PDF downloads : 3817

Post your comment

captcha   Reload  Can't read the image? click here to refresh

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version